LyrArc Article Gist
Medtronic's former CEO, Bill George, says Medtronic's plan to reincorporate in Ireland as part of the merger with Covidien is intended to make it possible to use cash piled up overseas. The cash overseas if repatriated to the U.S. would incur corporate taxes of 35%. Medtronic can use its overseas cash resources to finance the acquisition of Covidien. The combination of the two companies will enhance cash flow, says Medtronic's CEO, Omar Ishak. Covidien's overseas cash and future earning from its businesses is not subject to U.S. repatriation taxes. As a result the combined company following merger will have only 40% of total cash "trapped" overseas, compared to 60% before a merger.
Medtronic's former CEO, Bill George, says Medtronic's plan to reincorporate in Ireland as part of the merger with Covidien is intended to make it possible to use cash piled up overseas. The cash overseas if repatriated to the U.S. would incur corporate taxes of 35%. Medtronic can use its overseas cash resources to finance the acquisition of Covidien. The combination of the two companies will enhance cash flow, says Medtronic's CEO, Omar Ishak. Covidien's overseas cash and future earning from its businesses is not subject to U.S. repatriation taxes. As a result the combined company following merger will have only 40% of total cash "trapped" overseas, compared to 60% before a merger.
